Pathophysiology and therapy of the shock of myocardial infarction.
D000208:Acute Disease; D000818:Animals; D003331:Coronary Vessels / Q000503:physiopathology; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004106:Dilatation; D004195:Disease Models, Animal; D004298:Dopamine / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006439:Hemodynamics; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D012039:Regional Blood Flow; D012770:Shock, Cardiogenic / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D013566:Sympathomimetics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D004071:Digitalis Glycosides; D013566:Sympathomimetics; D014665:Vasodilator Agents; D005934:Glucagon; D007545:Isoproterenol; D004298:Dopamine